Showing results (101-110 of 137) with videos related to
Sort By:
Pageof 14
American Journal of Neurodegenerative Disease|January 29, 2015
Validation of an Alzheimer's disease assessment battery in Asian participants with mild to moderate Alzheimer's diseaseJoan Hq Shen, Qi Shen, Holly Yu, et al.Vaccine|August 17, 2021
Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvantKendall B Preston, Teri Ann S Wong, Albert To, et al.Journal of Medicinal Chemistry|October 3, 2003
Trisubstituted acridine derivatives as potent and selective telomerase inhibitorsR John Harrison, Javier Cuesta, Gianni Chessari, et al.Journal of Psychopharmacology (Oxford, England)|January 29, 2022
The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparationJames J Rucker, Lindsey Marwood, Riikka-Liisa J Ajantaival, et al.Melanoma Research|May 23, 2019
Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapyMegan C Duggan, Kelly Regan-Fendt, Gonzalo N Olaverria Salavaggione, et al.Journal for Immunotherapy of Cancer|May 30, 2019
Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitroBrooke Benner, Luke Scarberry, Lorena P Suarez-Kelly, et al.American Journal of Human Genetics|October 20, 2021
Establishing risk of vision loss in Leber hereditary optic neuropathyM Isabel G Lopez Sanchez, Lisa S Kearns, Sandra E Staffieri, et al.Journal of Alzheimer'S Disease : JAD|October 18, 2014
Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension studyMarcel G M Olde Rikkert, Frans R Verhey, Rafael Blesa, et al.Journal of Alzheimer'S Disease : JAD|February 19, 2010
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analysesNoel G Faux, Craig W Ritchie, Adam Gunn, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 22, 2025
Evaluation of cognitive, functional, and behavioral effects observed in EMERGE, a phase 3 trial of aducanumab in people with early Alzheimer's diseaseJeffrey Cummings, Sharon Cohen, Jennifer Murphy, et al.Pageof 14